[HTML] nih.gov

[HTML][HTML] Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to,'COVID-19: Immunology and treatment …

JR McIlroy, BH Mullish, SD Goldenberg… - Clinical Immunology …, 2020 - ncbi.nlm.nih.gov
In recent years several publications have demonstrated that a bidirectional dialogue exists
between the host immune system and its resident hidden microbial majority, specifically the …
被引用次数：15 相关文章

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to,'COVID-19: Immunology and treatment options' …

JR McIlroy, BH Mullish, SD Goldenberg… - Clinical Immunology …, 2020 - europepmc.org
We read the focussed review authored by Felsenstein and colleagues with great interest
and wish to add further perspective on a novel approach to immunotherapy in this patient …

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to,'COVID-19: Immunology and treatment options' …

JR McIlroy, BH Mullish… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced
hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein …

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to,'COVID-19: Immunology and treatment options' …

JR McIlroy, BH Mullish, SD Goldenberg… - Clinical Immunology …, 2020 - europepmc.org
In recent years several publications have demonstrated that a bidirectional dialogue exists
between the host immune system and its resident hidden microbial majority, specifically the …